Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 5

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
Ischemic postconditioning used at the right time after initial ischemia is able to protect the most vulnerable CA1 hippocampal neurons. Alteration of ubiquitin immunoreactivity (UIR) was studied after 7 days of reperfusion in 4 experimental groups of rats (1) 10 min of ischemia, (2) 10 min of ischemia followed by ischemic postconditioning (5 min of ischemia done after 2 days of reperfusion). Extract of Ginkgo biloba (EGb 761, 40 mg/kg; p.o.) was administered 5 h after 10 min of ischemia both in ischemic group (3) or ischemia/postconditioning group (4). Quantitative analysis showed signifi cant decrease (45.0 ± 9.7) of ubiquitin positive CA1 neurons in group (1) in comparison to sham control (187.5 ± 15.1) and nonsignifi cant increase of neuronal UIR (74.8 ± 22.4) in group (3) with EGb 761 administration. Ischemia/postconditioning (2) showed neuroprotection and signifi cant increase of ubiquitin positive CA1 neurons (133.4 ± 14.3). Ischemia/ postconditionig combined with antioxidant EGb 761 (4) revealed suppression of neuroprotective effect of delayed ischemic postconditioning. Moreover, signifi cant decrease of ubiquitin positive neurons (10.8 ± 2.4) in CA1 region was observed. Our results suggest that delayed ischemic postconditioning is able to prevent ischemia induced neurodegeneration while antioxidant used after initial ischemia followed by postconditioning fully abolishes this effect. This study was supported by VEGA grants: 1/4237/07, 2/0141/09 and APVV LPP 0235-06.
The present study examined the effects of a selective inducible nitric oxide synthase inhibitor, aminoguanidine (AG) on neuronal cell survival after middle cerebral artery occlusion (MCAO) in hippocampal CA1 region. Transient focal cerebral ischemia was induced in rats by 60 min MCAO, followed by 7 days of reperfusion. Saline as vehicle or AG at the dosage of 150 mg/kg i.p. was administered immediately after occlusion and thereafter twice a day for three days. The evaluation of infarcted volume was made by 2,3,5-triphenyltetrazolium chloride (TTC). For comparison of cellular viability we used Fluoro-Jade B and NeuN staining to examine the evolving phases of infarction induced by MCAO. Treatment with AG signifi cantly reduced total infarct volumes by 55% in comparison with saline group. AG signifi cantly improved the neurological outcome. The number of degenerating neurons was markedly reduced in hippocampal CA1 region compared to groups without AG treatment. These changes were seen in the ipsilateral and contralateral hippocampus. In conclusion, the focal ischemia affects the hippocampus, which responds bilaterally to the injury. Our fi ndings show that AG decreases ischemic brain damage and improves neurological recovery after transient ischemia induced by MCAO. It is suggested that treatment with AG may present a potential therapeutic strategy for the treatment of traumatic brain injury. This study was supported by VEGA 2/0141/09, VEGA 2/0146/09, VEGA 1/4237/07 and APVV LPP 0235-06.
Brain-derived neurotrophic factor (BDNF) acts on certain neurons of the central and peripheral nervous system, helps to support the survival, encourage the growth and differentiation of new neurons and synapses. In our study we monitored BDNF blood level in course of brain ischemia-reperfusion in rat models of transient focal (FI) and global (GI) ischemia. Blood samples were collected before and during ischemia and at 40 and 90 min of reperfusion. Results showed that in model of FI BDNF concentration in total blood, in plasma and blood cells rapidly decreased during fi rst 40 min of ischemia. In samples of whole blood and blood cells BDNF started to rise at the end of ischemic insult to control level, but in plasma it signifi cantly decreased. In model of GI we didn’t observe important changes after insult. During fi rst 90 min of reperfusion in both models BDNF level in total blood and in blood cells continuously decreased. Plasma level of BDNF started to rise at 40 min of reperfusion. At 90 min of recirculation BDNF level in model of FI reached 92%, in GI about 155%. In conclusion we can state that brain ischemia causes reduction of BDNF level during ischemia and subsequent elevation of BDNF concentration in blood cells at the end of ischemic insult followed by decreasing in early period of reperfusion. On the other side, plasma level of this protein reduced during ischemia markedly rises during recirculation. Supported by VEGA 2/0141/09, VEGA 2/0146/09, APVV LPP023506, APVV-51-002105.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.